Anthony Ting
Corporate Officer/Principal at International Society For Cell & Gene Therapy
Network origin in Anthony Ting first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
International Society For Cell & Gene Therapy
1
| Non-Profit Organization | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Anthony Ting via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University College London | College/University | Corporate Officer/Principal | |
Kuur Therapeutics Ltd.
 Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Founder | |
Royal Free London NHS Foundation Trust
 Royal Free London NHS Foundation Trust Hospital/Nursing ManagementHealth Services Royal Free London NHS Foundation Trust operates hospitals and clinics. The company was founded on July 1, 2014 and is headquartered in London, the United Kingdom. | Hospital/Nursing Management | Corporate Officer/Principal | |
| St Bartholomew's Hospital Medical College | College/University | Doctorate Degree | |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Founder | |
| INMUNE BIO, INC. | Biotechnology | Founder | |
| Royal Free Hospital Medical School | College/University | Corporate Officer/Principal | |
| Blizard Institute | College/University | Doctorate Degree | |
| ACHILLES THERAPEUTICS PLC | Pharmaceuticals: Major | Founder | |
| Immune Ventures Ltd. | Founder | ||
| Autolomous Ltd. | Founder |
Statistics
International
| United Kingdom | 11 |
| United States | 2 |
Sectoral
| Consumer Services | 5 |
| Health Technology | 5 |
| Health Services | 2 |
Operational
| Founder | 6 |
| Corporate Officer/Principal | 5 |
| Director/Board Member | 2 |
| Doctorate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Most connected contacts
| Insiders | |
|---|---|
| Mark Lowdell | 12 |
- Stock Market
- Insiders
- Anthony Ting
- Company connections
